Type 2 Diabetes with co-morbid anxiety disorder and/or depression Nutritional, Metabolic, Endocrine Type 2 Diabetes with co-morbid anxiety disorder and/or depression
Conditions
Interventions
Participants will receive an evidence-based cognitive behavioural therapy (CBT) treatment which will consist of weekly therapy appointments lasting 60 minutes. CBT will be delivered online, using sync
Sponsors
Roche Diabetes Care Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 years or older 2. Diagnosed with type 2 diabetes at least 12 months prior 3. Co-morbid anxiety disorder and/or depression
Exclusion criteria
Exclusion criteria: 1. Unsuitable for cognitive behavioural therapy 2. Unable to access an Internet-enabled device or no access to an Internet connection 3. Low level of literacy 4. Visually impaired and unable to write on or read from a computer, and unable to access appropriate assistive technology for the visually impaired 5. Unable to speak English 6. Unsuitable for treatment within a primary care psychological therapy service: 6.1. Patients who become actively suicidal or present as a risk to others will be referred to a more specialised, secondary care service 6.2. Patients experiencing symptoms of psychosis, hypermania, severe cognitive impairment, severe personality disorders or a severe learning disability are also unsuitable for the study and will be referred to more specialised services 7. Already involved in a different research project 8. Undergoing any other mental health therapy at present
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following are assessed at the baseline, post-intervention and at the 6 months follow-up: 1. Depression, assessed using the Patient Health Questionnaire (PHQ-9) 2. Anxiety, assessed using the Generalised Anxiety Disorder Assessment (GAD-7) | — |
Secondary
| Measure | Time frame |
|---|---|
| The following are assessed at the baseline, post-intervention and at the 6 months follow-up: 1. Patient activation level and knowledge, skill and confidence in measuring their long-term health condition, assessed using the Patient Activation Measure (PAM) via telephone 2. Distress (emotional burden, regimen distress, interpersonal distress and physician distress), assessed using the Diabetes Distress Scale (DDS) | — |
Countries
England, United Kingdom
Contacts
Public ContactAna Catarino
Outcome results
None listed